Development of parenteral drugs can be challenging due to the increasing complexity of biotherapeutics and changing regulatory landscape.
Our team of industry-leading experts will support you in bringing life-changing medicines to patients.
Depending on your program needs, we offer both full end-to-end services as well as stand-alone services to support
- Speed to clinic
- Entry into market
We provide fully integrated, phase-appropriate solutions to drug product development and manufacturing addressing formulation, process design, and primary packaging. This approach can help to differentiate your product and support your products lifecycle management.
Located in the Technology Park Basel, Switzerland, we run multiple development labs, with state-of-the art analytical, formulation and drug product processing equipment. Our facilities include:
- 13,000 square meters
- 25 development and testing labs
Secure your simplified biologics supply
To support your commercial success, Lonza is expanding large-scale biologics drug product manufacturing in Stein, Switzerland, providing you with end-to-end solutions through our global network. This enables seamless integration of drug substance and drug product for mammalian, microbial-based, and bioconjugate modalities.
Our locations
Locations where these services are provided